Volume 11, Issue 2 (2025)                   Pharm Biomed Res 2025, 11(2): 139-146 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fagbohun B O, Ogar O E, Messiah A I, Adewuyi H A, Adio W S, Oluwatoyin A H, et al . Antihypertensive Potential of Euphorbia hirta and Leptadenia hastata in Adrenaline-induced Wistar Rats. Pharm Biomed Res 2025; 11 (2) :139-146
URL: http://pbr.mazums.ac.ir/article-1-659-en.html
1- Department of Pharmacy Technician, Ogun State College of Health Science and Technology, Ogun, Nigeria.
2- Department of Chemical Engineering, University of Benin, Benin City, Nigeria.
3- Department of Biochemistry, Federal University of Technology, Minna, Nigeria.
4- Department of Chemistry and Biochemistry, College of Science, Old Dominion University, Norfolk, United States.
5- Department of Chemistry and Biochemistry, College of Health and Natural Sciences-Keplinger Hall, The University of Tulsa, Oklahoma, United States.
6- Department of Industrial Chemistry, College of Pure and Applied Chemistry, Osun State University Osogbo, Osun, Nigeria.
7- Department of Biochemistry, University of Ibadan, Oyo State Nigeria.
8- Department of Biological Sciences, AhmanPategi University, Pategi, Nigeria.
9- Department of Biological Sciences, Crawford University, Ketu Adieowe, Nigeria.
Abstract:   (76 Views)
Background: Hypertension is a major public health concern worldwide, contributing to cardiovascular morbidity and mortality. The use of plant-based therapies, such as Euphorbia hirta and Leptadenia hastata, has gained attention for their potential antioxidant, anti-hyperlipidemic, and organ-protective effects. 
Objectives: This study aimed to investigate the phytotherapeutic approach to hypertension using E. hirta and L. hastata extracts in adrenaline-induced hypertensive Wistar rats
Methods: Utilizing an adrenaline-induced hypertensive rat model, we assessed the effects of E. hirta and L. hastata leaf extracts (50, 100, and 200 mg/kg) on systolic blood pressure, renal function, lipid metabolism, and hematological parameters.
Results: Antioxidant activity: Increased levels of superoxide dismutase, catalase, and glutathione peroxidase. Lipid profiles: Reduced levels of total cholesterol, triglycerides, and LDL cholesterol. Liver function tests (LFTs): Decreased levels of alanine transaminase and aspartate transaminase. Hematological parameters: Improved red blood cell count, hemoglobin, and packed cell volume (PCV).
Conclusion: This preclinical investigation provides compelling evidence for the antihypertensive potential of E. hirta and L. hastata leaf extracts, validating their traditional use. These findings underscore the promise of these natural products as adjunctive therapeutics for hypertension management, warranting further clinical investigation.
Full-Text [PDF 600 kb]   (21 Downloads) |   |   Full-Text (HTML)  (12 Views)  
Type of Study: Original Research | Subject: Ehtnopharmacology

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb